For example: Apple Inc, UTIL, Aluminum
Lifevantage Corporation
NASDAQ:LFVN
Market Close 07/08
13.26 USD +0.23 (+1.77%)
OPEN:
13.00
DAY RANGE:
12.82 - 13.27
PE:
24.49
PB:
6.84
PS:
0.81
WTD % -6.22
MTD % -1.92
QTD % -1.92
YTD % -15.05
* Updated at market close
Lifevantage Corporation (NASDAQ:LFVN) opened on Jul 8, 2020 at 13.00 USD and increased by 1.77%. The intraday price range was 12.82 - 13.27 USD and eventually ended the session at 13.26 USD. The stock trade volume was 83,900.00 shares. The company's 52-week range is 7.75 - 17.25 USD.
Trading Statistics (Market Close Jul 8, 2020)
Market Cap 190.40 M
Outstanding Stock 14.34 M
Dividend 0.00
Dividend Yield 0.00
EPS 0.53
YTD Change -15.05%
52 Week's Range 7.75 - 17.25
Key Ratio & Margins (Market Close Jul 8, 2020)
Price/Earning 24.49
Price/Book Value 6.84
Price/Sales 0.81
ROA -
ROE -
Debt/Equity 1.03
Company Self Description
LifeVantage Corporation engages in the identification, research, development, and distribution of nutraceutical dietary supplements and skin care products. The company offers Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skin care product. It was founded in 1871 and is headquartered in Sandy, Utah, United States.
Business Information
Lifevantage Corporation
Sector Consumer Staples
Industry Personal Products
Exchange NASDAQ
Top Competitors (Market Close Jul 8, 2020)
  LFVN NATR NEPT VERU
Daily Change (%) 1.77 -2.72 5.35 0
WTD (%) -6.22 -1.65 10.14 -5.06
MTD (%) -1.92 -0.67 12.50 -4.49
QTD (%) -1.92 -0.67 12.50 -4.49
YTD (%) -15.05 0.22 14.55 -4.78
52-Week Change (%) 5.83 -2.51 -28.89 39.91
Stock Performance (Market Close Jul 8, 2020)
  LFVN NATR NEPT VERU
Daily Change (%) 1.77 -2.72 5.35 0
WTD (%) -6.22 -1.65 10.14 -5.06
MTD (%) -1.92 -0.67 12.50 -4.49
QTD (%) -1.92 -0.67 12.50 -4.49
YTD (%) -15.05 0.22 14.55 -4.78
52-Week Change (%) 5.83 -2.51 -28.89 39.91
Key Fundamentals (Market Close Jul 8, 2020)
  LFVN NATR NEPT VERU
Market Cap 190.40 M 174.28 M 296.86 M 207.97 M
Revenue Growth - - - -
Net Income Growth - - - -
Profit Margin 3.30% 0.80% -94.90% -59.70%
P/E Ratio 24.49 58.06 -14.63 -7.89
Price to Sales Ratio 0.81 0.49 13.81 4.74
Price to Book Ratio 6.84 1.30 4.85 2.66
Enterprise Value to EBITDA 15.04 8.15 -16.12 -4.25
ROA - 1.50% -24.60% -32.80%
ROE - 2.50% -29.80% -50.10%
Debt/Equity 1.03 0.60 0.31 0.64
Asset Turnover Ratio 4.20 1.82 0.26 0.55
Current Ratio 1.65 1.60 1.23 0.83
Dividend Yield 0.00 0 0 0
in USD
  Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
Revenue 225.96 M 203.20 M 199.49 M 206.54 M
Cost Of Revenue 37.97 M 34.85 M 33.46 M 33.93 M
Gross Profit 187.99 M 168.36 M 166.03 M 172.61 M
Selling General & Administrative Expenses 178.17 M 158.03 M 161.58 M 159.19 M
Research & Development 0.00 0.00 0.00 0.00
Operating Income 9.81 M 10.32 M 4.45 M 13.41 M
Net Income 7.43 M 5.76 M 1.61 M 6.11 M
EPS 0.53 0.41 0.12 0.44
Diluted EPS 0.50 0.41 0.11 0.42
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Revenue 56.17 M 56.01 M 58.17 M 55.61 M
Cost Of Revenue 9.71 M 9.27 M 9.79 M 9.20 M
Gross Profit 46.46 M 46.74 M 48.37 M 46.41 M
Selling General & Administrative Expenses 40.79 M 44.50 M 47.79 M 45.09 M
Research & Development 0.00 0.00 0.00 0.00
Operating Income 5.67 M 2.24 M 581,000.00 1.32 M
Net Income 3.91 M 1.78 M 829,000.00 911,000.00
EPS 0.28 0.13 0.06 0.07
Diluted EPS 0.26 0.12 0.06 0.06
in USD
  Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
Total Current Assets 43.19 M 38.94 M 35.55 M 43.11 M
Cash & Cash Equivalents 18.82 M 16.65 M 11.46 M 7.88 M
Total Assets 55.27 M 51.14 M 45.25 M 50.86 M
Total Current Liabilities 26.20 M 23.81 M 23.36 M 30.63 M
Total Liabilities 28.07 M 29.20 M 30.72 M 40.21 M
Shareholder's Equity 27.20 M 21.95 M 14.53 M 10.65 M
Outstanding Stock 14.34 M 14.31 M 14.23 M 14.01 M
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Total Current Assets 43.19 M 42.68 M 43.66 M 40.53 M
Cash & Cash Equivalents 18.82 M 15.91 M 18.99 M 17.12 M
Total Assets 55.27 M 54.11 M 54.09 M 51.92 M
Total Current Liabilities 26.20 M 27.48 M 28.76 M 23.59 M
Total Liabilities 28.07 M 29.36 M 33.08 M 28.39 M
Shareholder's Equity 27.20 M 24.75 M 21.02 M 23.53 M
Outstanding Stock 14.34 M 14.28 M 14.10 M 14.09 M
in USD
  Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
Net Cash Flow from Operations 17.79 M 13.26 M 6.60 M 6.04 M
Capital Expenditures -2.51 M -4.65 M -1.06 M -562,000.00
Net Cash Flow from Investing Activities -4.51 M -4.65 M -1.06 M -562,000.00
Net Cash Flow from Financial Activities -11.12 M -3.50 M -1.96 M -11.70 M
Free Cash Flow 15.28 M 8.61 M 5.54 M 5.47 M
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Net Cash Flow from Operations 6.98 M 13.26 M 6.60 M 6.04 M
Capital Expenditures -817,000.00 -1.42 M -186,000.00 -86,000.00
Net Cash Flow from Investing Activities -817,000.00 -1.42 M -786,000.00 -1.49 M
Net Cash Flow from Financial Activities -3.31 M -5.49 M -1.99 M -328,000.00
Free Cash Flow 6.17 M 2.45 M 4.39 M 2.28 M
Key Ratios (Market Close Jul 8, 2020)
Valuation Ratios 2020 2019 2018 2017
P/E Ratio 24.49 30.40 28.67 26.17
Price to Sales Ratio 0.81 0.90 0.84 0.73
Price to Book Ratio 6.84 4.15 4.24 17.89
Enterprise Value to EBIT 18.00 8.00 17.00 16.00
Enterprise Value to EBITDA 15.04 7.34 11.78 13.81
Profitability Ratios 2020 2019 2018 2017
Revenue Growth - - - -
Net Income Growth - - - -
ROA - - 12.20% 2.80%
ROE - - 29.70% 8.40%
Liquidity Ratios 2020 2019 2018 2017
Working Capital 16.99 M 15.13 M 12.19 M 12.48 M
Current Ratio 1.65 1.64 1.52 1.41
Efficiency & Capital Structure Ratios 2020 2019 2018 2017
Debt Equity Ratio 1.03 1.33 2.12 3.78
Asset Turnover Ratio - - 4.20 4.26
Scratchpad (max of 30 tickers)
Symbol Last Price Change
Empty Scratchpad
Portfolio (max of 30 tickers)
Login is required to view your portfolio.